CUSIP: 078771300
Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
1,073,492
-
Share change
-
+1,073,492
-
Total reported value
-
$11,765,734
-
Price per share
-
$10.96
-
Number of holders
-
16
-
Value change
-
+$11,765,734
-
Number of buys
-
16
Quarterly Holders Quick Answers
What is CUSIP 078771300?
CUSIP 078771300 identifies BLPH - BELLEROPHON THERAPEUTICS INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 078771300:
Institutional Holders of BELLEROPHON THERAPEUTICS INC - COM NEW (BLPH) as of Q1 2020
As of 31 Mar 2020,
BELLEROPHON THERAPEUTICS INC - COM NEW (BLPH) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,073,492 shares.
The largest 10 holders included
Puissance Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, BOXER CAPITAL, LLC, VANGUARD GROUP INC, Pennant Investors, LP, Telemetry Investments, L.L.C., Hudson Bay Capital Management LP, CVI Holdings, LLC, GEODE CAPITAL MANAGEMENT, LLC, and TOCQUEVILLE ASSET MANAGEMENT L.P..
This page lists
16
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.